GlassScriptPhysician profile
Marla Beth Bruns
NPI 1841453719
$229.68
in general payments reported to CMS, 2019-2025
8 companies · $26.64 in 2025
The $26.64 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $20.22 · 2023: $60.54 · 2024: $122 · 2025: $26.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $209.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $67.10 | 2023-2024 | |
| Ucb, INC. | $32.67 | 2024 | Fintepla |
| Mdd US Operations, LLC | $26.64 | 2025 | Gocovri |
| Lilly USA, LLC | $24.13 | 2024 | Kisunla |
| Amgen INC. | $21.61 | 2023 | Aimovig |
| Ipsen Biopharmaceuticals, INC | $20.22 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $18.84 | 2024 | Rexulti |
| Kyowa Kirin, INC. | $18.47 | 2023 | Nourianz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marla Bruns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.